# Noncovalent Btk
Suosituimmat podcast-jaksot
Päivitetty:
Top podcast episodes featuring noncovalent btk.
Noncovalent BTK Inhibitors: New Targeted Options for Relapsed or Refractory Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
CME credits: 1.00
Valid until: 24-09-2025
Claim your CME credit at https://reachmd.com/programs/cme/noncovalent-btk-inhibitors-new-targeted-options-for-relapsed-or-refractory-chronic-lymphocytic-leukemia-and-mantle-cell-lymphoma/24362/
This program addresses the educational needs for rela…
Noncovalent BTK Inhibitors: New Targeted Options for Relapsed or Refractory Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
CME credits: 1.00
Valid until: 24-09-2025
Claim your CME credit at https://reachmd.com/programs/cme/noncovalent-btk-inhibitors-new-targeted-options-for-relapsed-or-refractory-chronic-lymphocytic-leukemia-and-mantle-cell-lymphoma/24362/
This program addresses the educational needs for rela…
Current Clinical Practice and NCCN Guidelines for CLL/SLL
In this podcast episode, Farrukh Awan, MD, Jeremy S. Abramson, MD, MMSc, and Shuo Ma, MD, PhD, discuss real-world patient cases and how to align current clinical practice with the NCCN guidelines for CLL/SLL, including:
Prognostic variables when deciding between regimens
Role of MRD in CLL
Results…
Relapsed/Refractory Chronic Lymphocytic Leukemia: The Evolving Role of BTK Inhibitors
Did you know that the National Comprehensive Cancer Network (NCCN) guidelines now include an investigational noncovalent BTK inhibitor for the treatment of relapsed/refractory CLL? Credit available for this activity expires: 12/05/24 Earn Credit / Learning Objectives & Disclosures: https://www.meds…
Let's Talk Relapsed/Refractory Chronic Lymphocytic Leukemia: Expert Perspectives on Reversible BTK Inhibitors
Did you know studies have shown that noncovalent BTK inhibitors are efficacious in patients with covalent BTK inhibitor-pretreated CLL?
Credit available for this activity expires: 4/12/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990418?ecd=bdc_podcast_l…
BTK Inhibitors for CLL and MCL: What the Latest Data Mean for Our Patients
Did you know noncovalent BTK inhibitor therapy is now an option for patients with pretreated MCL who fail a prior covalent BTK inhibitor therapy?
Credit available for this activity expires: 3/21/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/989323?ecd=bdc…
Mazyar Shadman, MD, MPH, Peter A. Riedell, MD - Finding Treatment Synergy in CLL: Expert Consults on Advances With Targeted and Cellular Therapy
Go online to PeerView.com/AEQ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Are you prepared to achieve therapeutic synergy in CLL and leverage the potency of targeted platforms along with emerging cellular therapy options? Find out by watchi…
Chronic Lymphocytic Leukemia | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Chronic Lymphocytic Leukemia
Featuring perspectives from Dr Farrukh T Awan, Dr Bita Fakhri, Dr Kerry A Rogers and Dr William G Wierda, moderated by Dr Jeff Sharman, including the following topics:
Introduction (0:00)
Optimizing First-Line Therapy for Chronic Lymphocytic Leukemia (CLL) — Jeff Sharman, MD (1:44)
Emerging Ro…
Dr. Toby A. Eyre, MBChB, DipMedEd, MRCP, FRCPath, MD / Nirav Shah, MD, MS - Rebooting the BTK Inhibitor Sequence in MCL: Team-Centered Guidance on the Personalized Selection of Covalent and Noncovalent BTK Inhibitors in Relapsed/Refractory Disease
Go online to PeerView.com/FHV860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Are you ready for new options and more sequential treatment choices in mantle cell lymphoma (MCL)? This activity, led by two MCL experts, will help you prepare throug…
S3 Ep58: ASH Data Offer Treatment Direction for Oncology Nursing Professionals
In this episode of The Vitals, Nilesh Kalariya, PhD, AGPCNP-BC, AOCNP; and Laura J. Zitella, MS, RN, ACNP-BC, AOCN, discuss data from the 64th American Society of Hematology Annual Meeting and Exposition that have the greatest potential to change oncology nursing practice.
Kalariya, a nurse practi…
PODCAST-HAKUKONEET
Voit käyttää verkkosivustoamme etsiäksesi3,823,114-podcasteja ja195,616,119-jaksoja ihmisten, paikkojen tai aiheiden mukaan.
Tietoon sijoittaminen tuottaa parhaiten, joten kuuntelen podcasteja.
‐ Benjamin "Llamacorn" Franklin
MUOKKAA
Kiitos, kun autoit pitämään podcast-tietokantaa ajan tasalla.
